Chronic kidney disease (CKD) severity is associated with an increased risk for gastroparesis, according to a study published ...

Credit: Getty Images The KDIGO 2024 chronic kidney disease guideline replaces the 2012 version and provides essential guidance on evaluating and managing the disease in all its facets. The new KDIGO ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...

In the United States, chronic kidney disease affects an estimated 37 million adults, with many more at risk of acute kidney ...

Kidney disease often progresses silently, causing irreversible damage before symptoms appear. Simple tests like blood ...

China: A comprehensive global analysis has highlighted that nearly one in five people living with type 1 diabetes (T1D) are ...

Credit: Getty Images. Empagliflozin is a sodium-glucose co-transporter 2 inhibitor. The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of sustained ...

Millions of Americans have chronic kidney disease without knowing it - discover the warning signs and new treatments that ...